Falls Church, VA · Founded 2023 · Privately Held (backing)
Developer of therapeutic drugs designed for patients with hypertension. Retension Pharmaceutical is based in Falls Church, VA and was founded in 2023. Its last reported valuation was $50 million in May 2025. It has raised $22.4 million.
Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$22.4M
Last round
—
Team — not yet on record
No current team members for Retension Pharmaceutical are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Retension Pharmaceutical with a free account
·Watch Retension Pharmaceutical: the Monday email on marks, rounds and moves
